A broad bundle would include: composite
rate
services, ESRD-related separately billed injectable drugs, laboratory
tests used in furnishing dialysis services that are not currently
included in the composite rate, other dialysis related services,
MCP physicians’ services, outpatient vascular access maintenance, and
ESRD-related outpatient hospital services.
- CMS states that it has not conducted the analysis
needed to determine the feasibility of including MCP services,
outpatient vascular access services, or ESRD-related outpatient
hospital services in an expanded bundled.
A modified bundle would include:
composite rate services, ESRD-related
separately billed injectable drugs, laboratory tests used in furnishing
dialysis services that are not currently included in the composite
rate, and other dialysis related services (e.g., syringes).
Certain oral medications that substitute for injectable drugs commonly
used in ESRD patients (e.g., iron and vitamin D preparations) could
also be included in the bundle.
- CMS notes that bundled payments for services
furnished by dialysis facilities would cover 96 percent of composite
rate and separately billable services, with payments to independent
laboratories representing the remaining 4 percent.